Skip to main content
AMIA Annual Symposium Proceedings logoLink to AMIA Annual Symposium Proceedings
. 2020 Mar 4;2019:285–294.

Serial Heart Rate Variability Measures for Risk Prediction of Septic Patients in the Emergency Department

Calvin J Chiew 1,*, Han Wang 2,*,#, Marcus EH Ong 3,4,5, Ting Hway Wong 6, Zhi Xiong Koh 5, Nan Liu 3,4,^, Mengling Feng 2,^
PMCID: PMC7153136  PMID: 32308821

Abstract

In this study, we used serial heart rate variability (HRV) measures over 2 hours to improve the prediction of 30-day in-hospital mortality among septic patients in the emergency department (ED). We presented a generalizable methodology for processing and analysing HRV time series (HRVTS) data which may be noisy and incomplete. Feature sets were created from the HRVTS data of 162 patients with suspected sepsis using aggregation-based, deltabased and regression-based series-to-point transformations, and modelled over 100 random stratified splits. An optimized feature set comprising 12 selected HRVTS features performed better than baseline feature sets which only included patient demographics, vital signs and single time-point HRV measures taken at triage. This improved risk stratification approach could be used in the ED to identify high-risk septic patients for appropriate management and disposition.

Introduction

Sepsis is an increasingly recognised global problem that has a 10-20% in-hospital mortality (IHM) rate1-3. Risk stratification of septic patients in the Emergency Department (ED) may help to guide appropriate management and disposition, thereby reducing morbidity and mortality4-6. A number of clinical tools, such as the Quick Sequential Organ Failure Assessment (qSOFA), National Early Warning Score (NEWS) and Modified Early Warning Score (MEWS), have been used to risk stratify septic patients in the ED, where certain clinical information, such as laboratory investigations, are initially not available. These risk calculators rely solely on patient demographics, vital signs and clinical observations in their scoring criteria.

Several studies have reported the prognostic value of heart rate variability (HRV) parameters in septic patients presenting to the ED7-9. Septic patients have reduced sympatho-vagal balance and impaired sympathetic activity, which lead to varying degrees of cardiac autonomic dysfunction10. This can be detected by HRV analysis, a quick, non-invasive technique of evaluating the beat-to-beat variation in heart rate. HRV analyses are divided into linear and non-linear methods11. Linear methods include HRV parameters measured in time or frequency domains. Time domain HRV parameters are statistical calculations of consecutive R-R time intervals and how they correlate with each other. Frequency domain HRV parameters are based on spectral analysis. Studies have suggested that regulators of the cardiovascular system interact in a non-linear way12, 13 and HRV analysis using non-linear methods reflect these mechanisms14.

We previously demonstrated that HRV parameters measured at triage, combined with patient demographics and vital signs, can improve the prediction of 30-day IHM among septic patients in the ED compared to traditional risk stratification tools15,16. Since sicker patients are often put on continuous electrocardiogram (ECG) monitoring in the ED, their serial HRV measurements over time can also be derived. We postulated that HRV time series (HRVTS) may embed more prognostic information than HRV parameters derived at a single time-point, such as at triage.

To date, there has been no published study exploring the use of HRVTS for risk prediction in sepsis. Thus, in this study, we aimed to compare the performance of HRVTS over 2 hours against single time-point HRV measures at triage, in the prediction of 30-day IHM among adult septic patients in the ED setting. In addition, since serial HRV measures are seldom encountered in literature, we aimed to develop and present a generalizable methodology for processing and analysing such data which may be noisy and incomplete.

Methods

Data preparation

Ethics approval for the study was obtained from SingHealth’s Centralised Institutional Review Board (CIRB, Reference Number 2016/2858), with waiver of patient consent. Patients above 21 years old who presented to the Singapore General Hospital (SGH) ED between September 2014 and April 2016 with clinically suspected sepsis, and who met at least 2 of the 4 Systemic Inflammatory Response Syndrome (SIRS) criteria17 were included. The SIRS criteria are temperature (<36°C or >38°C), heart rate (>90 beats/min), respiratory rate (>20 breaths/min) and total white count (<4000/mm3 or >12000/mm3).

Patient demographics (age, gender, ethnicity), first set of vital signs recorded at triage (temperature, respiratory rate, heart rate, systolic and diastolic blood pressures, and Glasgow Coma Scale (GCS) score), and outcome of interest (IHM within 30 days of ED admission) were retrieved from the hospital’s electronic medical records. Continuous one-lead ECG tracings over 2 hours in the ED were also obtained from X-Series Monitor (ZOLL Medical Corporation, Chelmsford, MA). The ECGs were split into 8 intervals of 15 minutes each and then analysed for HRV parameters using the most stable continuous 5-minute segment within each interval. 22 HRV measures in time, frequency and non-linear domains were computed for each interval. For patients whose ECGs were shorter than 2 hours or unanalysable due to non-sinus rhythm, excessive artifacts and/or ectopic beats, their data was considered missing for the relevant intervals.

To ensure data quality and to limit the amount of missing data in subsequent analysis, we only included patients with at least 7 of the 8 intervals in our final analysis (i.e. at most 1 missing interval allowed). Univariate statistical analysis was conducted to compare patients with and without outcome, as well as to compare the original and final cohorts (Kruskal-Wallis H test for continuous variables and Chi-squared test for categorial variables).

Feature Extraction

We created 2 baseline feature sets that did not utilize any information from the HRVTS as baselines for comparison. We then designed 3 groups of candidate feature sets (aggregation-based, delta-based and regression-based) using different methods of series-to-point transformations to encapsulate the HRVTS information. Detailed definitions of the feature sets, as well as an example of how the feature sets were calculated, are presented in Tables 1 and 2 respectively.

Table 1.

Definitions of the feature sets with feature values calculated based on the example mean_rr HRVTS.

Category Feature set Definition of features (additional to fs_no_HRV) Name of HRV features Feature value
Baseline fs_no_HRV Only gender, race, age and the vital signs - -
fs_baseline First 5-min HRV parameter at triage mean_rr 510.00
Aggregation based fs_first_last First and last value of HRVTS first_mean_rr 514.00
last_mean_rr 488.00
fsmedlQR Median and inter-quantile range of HRVTS median_mean_rr 501.00
IQR_mean_rr 65.00
fs_min_max Minimum and maximum of HRVTS min_mean_rr 406.00
max_mean_rr 632.00
Delta based fs_delta_first_last First and last of all the differences in absolute value between neighbouring intervals delta_first_mean_rr 58.00
delta_last_mean_rr 46.00
fsdeltamedlQR Median and inter-quantile range of all the differences in absolute value between neighbouring intervals delta_median_mean_rr 78.00
delta_IQR_mean_rr 57.25
fs_delta_min_max Minimum and maximum of all the differences in absolute value between neighbouring intervals delta_min_mean_rr 50.00
delta_max_mean_rr 113.00
Regression based fs_reg_default Coefficient and intercept of the linear regression model fit on the HRVTS coef_mean_rr 10.86
intercept_mean_rr 463.57
fs_reg_delta Coefficient and intercept of the linear regression model fit on the series of the differences in absolute value between neighbouring intervals coef_delta_mean_rr 2.40
intercept_delta_mean_rr 71.27
fs_reg_cum_delta Coefficient and intercept of the linear regression model fit on the series of cumulative sum of all the differences in absolute value between neighbouring intervals coef_cum_delta_mean_rr 91.00
intercept_cum_delta_mean_rr -46.67

Table 2.

Example of a patient’s mean_rr HRVTS and derived values for the calculation of features. The 4th interval was missing, and the interpolated value is indicated by an underline.

Time Mean_rr Derived from raw value Absolute delta Derived from absolute delta Cumulative Derived from cumulative absolute delta
1 514.00 median 501.00 58.00 median 78.00 58.00 Linear Regression y = 91.00x-46.67
2 456.00 50.00 108.00
3 406.00 IOR 65.00 113.00 IOR 57.25 221.00
4 missing 113.00 334.00
5 623.00 Linear Regression y = 10.86x+463.57 98.00 Linear Regression y = 2.40x+71.27 432.00
6 534.00 46.00 478.00
7 488.00 - -
Baseline 510.0 - -

(HRVTS, heart rate variability time series; mean_rr, average width of the RR interval)

Baseline feature sets: The first baseline feature set (fs_no_HRV) contained only patient demographics and vital signs. These features are included in all subsequent feature sets. In the second baseline feature set (fs_baseline), single time-point HRV parameters generated from the first 5-minutes of ECG obtained at triage were added.

Aggregation-based features sets: 3 aggregation-based feature sets were constructed by taking (1) the first and last values of the HRVTS (fs_first_last), (2) the median and interquartile range (IQR) of the HRVTS (fs_med_IQR), and (3) the minimum and maximum values of the HRVTS (fs_min_max).

Delta-based feature sets: With the assumption that the magnitude of relative changes between neighbouring intervals were informative, we calculated (1) the first and last (fs_delta_first_last), (2) the median and IQR (fs_delta_med_IQR), and (3) the minimum and maximum (fs_delta_min_max) of the absolute differences between adjacent HRVTS measurements. Linear interpolation was used to impute missing measurements.

Regression-based feature sets: With the assumption that trends in the HRVTS were informative, we fitted the (1) original values (fs_reg_default), (2) absolute differences between measurements (fs_reg_delta), and (3) cumulative differences between measurements (fs_reg_cum_delta) of the HRVTS to a linear regression model using the ordinary least squares method. The linear coefficients and intercepts obtained were used as features to characterize the trends.

Model Setup

Prior to modelling, all features were standardized to be between 0 to 1 by MinMaxScaler (subtracting the minimum value and then dividing by the difference between the maximum and minimum values).

We set aside 20% of the patients as test data, stratified by outcome. Within the remaining 80% of the patients, we created 100 random stratified splits, with 80% as training data and 20% as validation data in each split. We chose logistic regression with L1 regularization (LASSO) with C=1.0 as our model due to its simplicity and the interpretability of odds ratios obtained. Class imbalance was addressed by applying sample weights inversely proportional to the number of samples. We used Area Under the Receiver Operating Characteristic curve (AUC) as our performance evaluation metric.

Feature Selection

Each feature set was inputted separately into the logistic regression model and the median odds ratios of all non-zero coefficients obtained across 100 splits were calculated. We tested the proportion of each feature having non-zero coefficient larger than 0.5 using one-sided binomial test under Bonferroni correction.

To create an optimized feature set, the feature with the most extreme odds ratio among statistically significant ones (if any) was selected for each HRV parameter. These selected HRV features were then combined with demographic and vital sign variables significant across majority of feature sets to form an optimized feature set fs_final_selection.

HRV analysis was performed using Kubios HRV software version 2.2 (Kuopio, Finland)18. Statistical analysis and modelling were carried out in Python 3.6 (Python Software Foundation, Wilmington, Delaware, USA) using the statsmodel19 and scikit-learn libraries20.

Results

Figure 1 shows the cohort selection process. 214 patients were in the original cohort whose ECGs were split into intervals and analysed for HRV parameters. After excluding patients with more than 1 missing interval, 162 patients were included in the final cohort, of whom 31 (19.1%) met the outcome. There were no significant differences in the patient demographics, vital signs and outcome between the original and final cohorts (Table 3).

Figure 1.

Figure 1.

Cohort selection flowchart.

Table 3.

Patient demographics and vital signs of the original and final cohorts used in the analysis.

Original Cohort Final Cohort Original vs. Final
Characteristics No 30-day IHM 30-day IHM P-Value No 30-day IHM 30-day IHM P-Value P-Value
n (%) 174 (81.3) 40 (18.7) - 131 (80.8) 31 (19.2) - 0.981
Age (years) 66.0 [56.2,76.8] 76.0 [67.8,83.0] <0.001 66.0 [57.0,77.0] 76.0 [68.0,83.0] 0.002 0.806
Male gender 88 (50.6) 20 (50.0) 0.913 62 (47.3) 15 (48.4) 0.925 0.646
Ethnicity (%)
Chinese 125 (71.8) 30 (75.0) Ref. 97 (74.0) 25 (80.6) Ref. Ref.
Malay 25 (14.4) 4 (10.0) 0.637 16(12.2) 4(12.9) 1.000 0.850
Indian 15 (8.6) 5(12.5) 0.545 11 (8.4) 1(3.2) 0.465 0.631
Others 9(5.2) 1(2.5) 0.692 7(5.3) 1(3.2) 1.000 0.901
Temperature (°C) 38.3 [37.4,38.8] 37.4 [36.5,38.5] 0.005 38.3 [37.2,38.9] 37.1 [36.0,38.7] 0.010 0.844
Respiratory rate (breaths/min) 19.0 [18.0,22.0] 22.0 [18.8,26.0] <0.001 19.0 [18.0,21.5] 22.0 [18.5,24.5] 0.009 0.794
Heart rate (beats/min) 118.0 [105.0,130.0] 108.5 [97.8,125.5] 0.078 118.0 [105.0,131.0] 106.0 [97.0,113.0] 0.009 0.751
Systolic BP (mmHg) 114.0 [91.0,142.8] 105.0 [91.0,126.2] 0.097 115.0 [90.5,145.0] 102.0 [86.0,119.5] 0.042 0.926
Diastolic BP (mmHg) 63.0 [55.0,74.0] 61.5 [52.0,70.2] 0.442 63.0 [55.0,75.0] 61.0 [50.0,68.5] 0.204 0.995
GCS score 15.0 [13.2,15.0] 14.0 [9.0,15.0] 0.002 15.0 [14.0,15.0] 14.0 [9.0,15.0] 0.006 0.779

(BP, blood pressure; GCS, Glasgow Coma Scale)

For continuous variables, data is presented in medians and interquartile ranges. Kruskal-Wallis H test was used to test for differences. For categorical variables, data is presented in frequencies and percentages. Chi-square test was used to test for association.

Among the final cohort, 77 (47.5%) of the patients were male, with median age of 67 years (inter-quartile range, IQR 57–79). Patients who met the outcome were older (median age 76 years; IQR 68–83 years) than those who did not (median age 66 years; IQR 57–77 years). There were no significant differences in gender and ethnicity distributions between the two groups. In terms of vital signs, patients who met the outcome had higher respiratory rates, as well as lower temperatures, heart rates, systolic blood pressures and GCS scores, compared to patients who did not meet the outcome. The HRVTS of the two groups are visualised in Figure 2.

Figure 2.

Figure 2.

Visualization of HRVTS for patients with outcome (orange) and without outcome (blue). (a) Time domain parameters (b) Non-linear domain parameters (c) Frequency domain parameters.

Table 4 shows the median odds ratios across all feature sets and predictor variables. Most of the features had coefficients of zero (hence odds ratio of zero) due to the L1 regularization. 12 HRV parameters (5 in time domain, 4 in frequency domain and 3 in non-linear domain) had statistically significant odds ratios and were selected into the optimized feature set fs_final_selection (Table 5). 3 other non-HRV variables (age, systolic blood pressure and GCS) were also statistically significant across most feature sets and added to the optimized feature set fs_final_selection to make a total of 15 features.

Table 4.

Median odds ratio of all the features. Green cells indicate odds ratio >1, and red cells indicate odds ratio <1. The darker the color, the stronger the odds ratio deviates from 1. All significant features are in black text. Values with a blue box are selected for fs_final_selection.

graphic file with name 3200772t1.jpg

Mean RR, average width of the RR interval; SD RR, standard deviation of all RR intervals; HR, heart rate; RMSSD, root mean square of differences between adjacent RR intervals; NN50, number of consecutive RR intervals differing by more than 50 ms; pNN50, percentage of consecutive RR intervals differing by more than 50 ms; TINN, baseline width of a triangle fit into the RR interval histogram using a least squares; VLF, very low frequency; LF, low frequency; HF, high frequency; norm, normalized; LF/HF, ratio of LF power to HF power; DFA, detrendedfluctuation analysis; BP, blood pressure; GCS, Glasgow Coma Scale.

Table 5.

Features in the optimized feature set fs_final_selection

Featurization From Feature Set
Time Domain
Mean RR (s) Minimum fs min max
Mean HR (bpm) Intercept fs reg default
NN50 (count) Last fs delta first last
RR triangular index Median fsdeltamedIQR
TINN Last fs first last
Frequency Domain
VLF power (ms2) Minimum fs delta min max
LF power norm (n.u.) Intercept fs reg delta
HF power norm (n.u.) Minimum fs min max
LF/HF Intercept fs reg delta
Non-linear Domain
Approximate entropy Coef fs reg cum delta
Sample entropy IQR fs delta med IQR
DFA, a-1 Intercept fs reg delta
Demographics
Age Original all
Systolic BP (mmHg) Original all
GCS score Original all

Figure 3 summarizes the median AUC of all feature sets over 100 training splits. The optimized HRVTS feature set fs_final_selection achieved the highest median AUC of 0.82, followed by the candidate feature set fs_min_max which achieved median AUC of 0.77. Both performed better than baseline feature sets which do not contain HRVTS information, namely fs_no_HRV (median AUC 0.68) and fs_baseline (median AUC 0.70). Figure 4 compares the median Receiver Operating Characteristic (ROC) curves of these four feature sets over 100 training splits. Table 6 reports the AUC achieved on the test set by these four feature sets. fs_final_selection outperformed the rest by a significant margin, while fs_min_max did not perform well, suggesting potential overfitting with single featurization method.

Figure 3.

Figure 3.

Median AUCs of all feature sets over 100 training splits.

Figure 4.

Figure 4.

Receiver Operating Characteristics (ROC) curves of fs_final_selection, fs_min_max and two baseline feature sets. AUCs reported in median ± IQR over 100 training splits.

Table 6.

Summary of median AUC achieved on validation sets and AUC achieved on test set.

Feature Set Median AUC (Validation) AUC (Test)
fs_no_HRV 0.68 0.57
fs_baseline 0.70 0.67
fs min max 0.77 0.63
fs_final_selection 0.82 0.76

Discussion

In this study, we used HRVTS data collected over 2 hours to improve the 30-day IHM prediction of septic patients on continuous ECG monitoring in the ED. An optimized feature set comprising 12 selected HRVTS features performed better than baseline feature sets which only included patient demographics, vital signs and single time-point HRV measures obtained at triage. This improved risk stratification could be used to inform management and disposition, such as early antibiotic therapy and ICU admission for identified high-risk patients.

While more research is needed to understand the physiological meaning and significance of each of the HRV parameters, studies have shown that HRV measures correlate with autonomic function21 and are predictive of adverse outcomes in septic patients. We hypothesize that higher-order dynamics and interactions in a HRVTS, including relative changes and trends over time may carry more prognostic information than the actual values of the HRV parameters themselves. This may explain why delta-based and regression-based features derived from HRVTS appear to be important risk predictors in our model.

We comprehensively explored various methods of feature engineering and selection to synthesize and make sense of the HRVTS data. In particular, our featurization method transforms a large number of data points for each patient into 15 key predictors and handles missing data. With the widespread adoption of wearable devices connected to the Internet of Things, we believe this type of high-resolution, high-volume time series data will become increasingly available. Therefore, the importance of our work lies in developing a methodology for processing and analysing HRVTS data which could be generalizable to other clinical settings and outcomes of interest, rather than in presenting a predictive model to be applied globally.

Our outcome of interest was IHM within 30 days during the same admission where the vitals and ECG were taken. Some studies did not specify a time period for mortality22 or if it was strictly within the same admission or not23. We chose this endpoint as it is more likely to be sepsis-related compared to an out-of-hospital mortality or mortality from a subsequent admission. It is also more meaningful for physicians in terms of administering possible interventions such as closer monitoring and more aggressive management of high-risk patients24.

Our study had several limitations. Firstly, this was a single-institution study with a small sample size. Larger multi-centre prospective studies are required to validate our results. Secondly, we had included patients in our study based on clinical suspicion of sepsis and meeting at least 2 of the 4 SIRS criteria. Sepsis largely remains a clinical diagnosis and there is no gold standard to determine whether a patient is septic. Other studies have attempted to address this issue by including only patients with administered intravenous antibiotics, blood culture investigations or confirmed source of infection22,24. We acknowledge that our cohort definition reflects suspected sepsis rather than confirmed sepsis. However, we believe this is reasonable given our eventual application in the ED where laboratory test results and confirmed diagnoses may not yet be available. In addition, while the SIRS criteria has recently been replaced with a new state of sepsis, defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection, the usefulness of the SIRS criteria in diagnosis of sepsis was still emphasized by the same task force25, 26.

Thirdly, even though HRVTS can improve mortality prediction in suspected sepsis patients as shown in this study, they require more time and effort to obtain than single time-point HRV measures. Currently, we are developing a wearable device which can continuously monitor a patient’s ECG and automatically perform HRV analysis in real-time.

Fourthly, the time frame of 2 hours was chosen in this study based on the duration most patients spend in the ED while awaiting admission. Nevertheless, in our future studies, it is definitely worthwhile to explore the utility of HRVTS over a much longer period (such as 24-72 hours) and extending into the inpatient ward setting, as well as assess whether HRV-based risk predictions impact clinical management and outcomes. As continuous ECG data is inherently noisy (for example, due to patient movement or temporary disconnection), we chose to split the ECGs into 8 intervals of 15 minutes so that there is sufficient temporal window within each interval to capture a valid 5-minute segment for HRV analysis. However, this could have resulted in loss of information. Further study is needed to understand how we can better achieve granularity with noisy data.

Lastly, LASSO may arbitrarily select features from collinear groups, and further efforts should be put into interpreting the selected features and their odds ratios.

Conclusion

Serial HRV measurements over 2 hours can be used to improve prediction of 30-day IHM among septic patients in the ED compared to single time-point HRV measures taken at triage. This approach could be used in the ED to identify high-risk septic patients for appropriate management and disposition. In addition, the feature extraction and selection pipeline used in this paper could be applied to other short, noisy and incomplete time series data.

Acknowledgments

We would like to thank our research assistant Ms. Kavita Govintharasah for her contribution in pre-processing the data for this project. This work is partially supported by National University of Singapore Start-up Grant WBS R-608-000-172-133.

Figures & Table

References

  • 1.Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369:840–51. doi: 10.1056/NEJMra1208623. [DOI] [PubMed] [Google Scholar]
  • 2.Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med. 2013;41:1167–74. doi: 10.1097/CCM.0b013e31827c09f8. [DOI] [PubMed] [Google Scholar]
  • 3.Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med. 2012;40:754–61. doi: 10.1097/CCM.0b013e318232db65. [DOI] [PubMed] [Google Scholar]
  • 4.Liu B, Ding X, Yang J. Effect of early goal directed therapy in the treatment of severe sepsis and/or septic shock. Curr Med Res Opin. 2016;32:1773–82. doi: 10.1080/03007995.2016.1206872. [DOI] [PubMed] [Google Scholar]
  • 5.Nguyen HB, Rivers EP, Havstad S, et al. Critical care in the emergency department: a physiologic assessment and outcome evaluation. Acad Emerg Med. 2000;7:1354–61. doi: 10.1111/j.1553-2712.2000.tb00492.x. [DOI] [PubMed] [Google Scholar]
  • 6.Rhodes A, Evans LE, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock. Intensive Care Med. 2017;43:304–77. doi: 10.1007/s00134-017-4683-6. [DOI] [PubMed] [Google Scholar]
  • 7.Barnaby D, Ferrick K, Kaplan DT, Shah S, Bijur P, Gallagher EJ. Heart rate variability in emergency department patients with sepsis. Acad Emerg Med. 2002;9:661–70. doi: 10.1111/j.1553-2712.2002.tb02143.x. [DOI] [PubMed] [Google Scholar]
  • 8.Chen WL, Chen JH, Huang CC, Kuo CD, Huang CI, Lee LS. Heart rate variability measures as predictors of in-hospital mortality in ED patients with sepsis. Am J Emerg Med. 2008;26:395–401. doi: 10.1016/j.ajem.2007.06.016. [DOI] [PubMed] [Google Scholar]
  • 9.Chen WL, Kuo CD. Characteristics of heart rate variability can predict impending septic shock in emergency department patients with sepsis. Acad Emerg Med. 2007;14:392–7. doi: 10.1197/j.aem.2006.12.015. [DOI] [PubMed] [Google Scholar]
  • 10.Scheff JD, Griffel B, Corbett SA, Calvano SE, Androulakis IP. On heart rate variability and autonomic activity in homeostasis and in systemic inflammation. Math Biosci. 2014;252:36–44. doi: 10.1016/j.mbs.2014.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Eur Heart J. 1996;17:354–81. [PubMed] [Google Scholar]
  • 12.Chialvo DR, Jalife J. Non-linear dynamics of cardiac excitation and impulse propagation. Nature. 1987;330:749–52. doi: 10.1038/330749a0. [DOI] [PubMed] [Google Scholar]
  • 13.Krogh-Madsen T, Christini DJ. Nonlinear dynamics in cardiology. Annu Rev Biomed Eng. 2012;14:179–203. doi: 10.1146/annurev-bioeng-071811-150106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sassi R, Cerutti S, Lombardi F, et al. Advances in heart rate variability signal analysis: joint position statement by the e-Cardiology ESC Working Group and the European Heart Rhythm Association co-endorsed by the Asia Pacific Heart Rhythm Society. Europace. 2015;17:1341–53. doi: 10.1093/europace/euv015. [DOI] [PubMed] [Google Scholar]
  • 15.Chiew CJ, Liu N, Tagami T, Wong TH, Koh ZX, Ong MEH. Heart rate variability based machine learning models for risk prediction of suspected sepsis patients in the emergency department. Medicine. 2019;98 doi: 10.1097/MD.0000000000014197. e14197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Samsudin MI, Liu N, Sumanth M, et al. A novel heart rate variability based risk prediction model for septic patients presenting to the emergency department. Medicine. 2018 doi: 10.1097/MD.0000000000010866. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644–55. doi: 10.1378/chest.101.6.1644. [DOI] [PubMed] [Google Scholar]
  • 18.Tarvainen MP, Niskanen JP, Lipponen JA, Ranta-Aho PO, Karjalainen PA. Kubios HRV--heart rate variability analysis software. Comput Methods Programs Biomed. 2014;113:210–20. doi: 10.1016/j.cmpb.2013.07.024. [DOI] [PubMed] [Google Scholar]
  • 19.Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with Python. Proceedings of the 9th Python in Science Conference. 2010 [Google Scholar]
  • 20.Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: machine learning in Python. J Mach Learn Res. 2011;12:2825–30. [Google Scholar]
  • 21.Tulppo MP, Kiviniemi AM, Hautala AJ, et al. Physiological background of the loss of fractal heart rate dynamics. Circulation. 2005;112:314–9. doi: 10.1161/CIRCULATIONAHA.104.523712. [DOI] [PubMed] [Google Scholar]
  • 22.Churpek MM, Snyder A, Han X, et al. Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med. 2017;195:906–11. doi: 10.1164/rccm.201604-0854OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Wang JY, Chen YX, Guo SB, Mei X, Yang P. Predictive performance of quick sepsis-related organ failure assessment for mortality and ICU admission in patients with infection at the ED. Am J Emerg Med. 2016;34:1788–93. doi: 10.1016/j.ajem.2016.06.015. [DOI] [PubMed] [Google Scholar]
  • 24.Freund Y, Lemachatti N, Krastinova E, et al. Prognostic accuracy of sepsis-3 criteria for in-hospital mortality among patients with suspected infection presenting to the emergency department. JAMA. 2017;317:301–8. doi: 10.1001/jama.2016.20329. [DOI] [PubMed] [Google Scholar]
  • 25.Balk RA. Systemic inflammatory response syndrome (SIRS): where did it come from and is it still relevant today? Virulence. 2014;5:20–6. doi: 10.4161/viru.27135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3) JAMA. 2016;315:801–10. doi: 10.1001/jama.2016.0287. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from AMIA Annual Symposium Proceedings are provided here courtesy of American Medical Informatics Association

RESOURCES